Hidehiko Nakagawa Selected Research

Neoplasms (Cancer)

1/2022	FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
1/2021	Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors.
1/2021	Live-Cell Imaging of Sirtuin Activity Using a One-Step Fluorescence Probe.
9/2020	Synthesis of artificial substrate based on inhibitor for detecting LSD1 activity.
11/2019	Ratiometric assay of CARM1 activity using a FRET-based fluorescent probe.
10/2019	Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.
1/2019	An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
1/2017	Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets.
10/2016	A Fluorescent Probe for Imaging Sirtuin Activity in Living Cells, Based on One-Step Cleavage of the Dabcyl Quencher.
2/2016	Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidehiko Nakagawa Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 02/2005
6	Colonic Neoplasms (Colon Cancer) 01/2016 - 05/2009
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 10/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2016 - 01/2016
2	T-Cell Lymphoma (Lymphoma, T Cell) 03/2014 - 11/2012
2	Breast Neoplasms (Breast Cancer) 11/2007 - 08/2007
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Bites and Stings (Sting) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 10/2019
1	Triple Negative Breast Neoplasms 10/2019
1	Insulin Resistance 10/2019
1	Rheumatoid Arthritis 01/2018
1	Erectile Dysfunction 01/2016
1	Inflammation (Inflammations) 01/2015
1	Neuroblastoma 11/2012
1	Parkinson Disease (Parkinson's Disease) 06/2012
1	Huntington Disease (Huntington's Disease) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Carcinogenesis 12/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2007
1	Brain Ischemia (Cerebral Ischemia) 03/2007
1	Hepatocellular Carcinoma (Hepatoma) 07/2005
1	Liver Diseases (Liver Disease) 07/2005

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 01/2020 - 02/2005
3	Histones (Histone)IBA 01/2018 - 02/2005
3	Sirtuin 1IBA 10/2009 - 05/2009
2	LigandsIBA 01/2022 - 10/2019
2	SirtuinsIBA 01/2021 - 10/2016
2	Biological ProductsIBA 09/2020 - 06/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2013
2	Amyloid (Amyloid Fibrils)IBA 11/2016 - 01/2016
2	Lysine (L-Lysine)FDA Link 02/2016 - 08/2010
2	Histone DemethylasesIBA 02/2016 - 08/2010
2	Coloring Agents (Dyes)IBA 04/2011 - 04/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 11/2007 - 02/2005
1	tacrolimus binding protein 4 (FKBP52)IBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2022
1	CaspasesIBA 01/2021
1	Lysophosphatidic Acid ReceptorsIBA 01/2020
1	lysophosphatidic acidIBA 01/2020
1	coactivator-associated arginine methyltransferase 1IBA 11/2019
1	Glycoproteins (Glycoprotein)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	EstersIBA 01/2019
1	Cyclin D1IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	IsoenzymesIBA 01/2018
1	4,6-dinitro-o-cresol (DNOC)IBA 02/2016
1	Protein AggregatesIBA 01/2016
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2015
1	N- hydroxy- 3- (1- (phenylthio)methyl- 1H- 1,2,3- triazol- 4- yl)benzamideIBA 03/2014
1	methyl-lysineIBA 09/2013
1	CohesinsIBA 11/2012
1	TubulinIBA 06/2012
1	Sirtuin 2IBA 06/2012
1	mitotracker green FMIBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	oxalylglycineIBA 08/2010
1	Proteins (Proteins, Gene)FDA Link 08/2010
1	ProdrugsIBA 08/2010
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 08/2010
1	Estrogens (Estrogen)FDA Link 11/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2007
1	Estrogen Receptor alphaIBA 11/2007
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2007
1	LipidsIBA 03/2007
1	CopperIBA 07/2005
1	Superoxide DismutaseIBA 07/2005
1	MetallothioneinIBA 07/2005
1	ZincIBA 07/2005

Therapy/Procedure

4	Therapeutics 01/2017 - 09/2013